BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//YourSite//YourCalendar//EN
BEGIN:VEVENT
UID:6ac456a33a486@yourdomain.com
DTSTAMP:20261006T020211Z
DTSTART:20251022T143000Z
DTEND:20251022T153000Z
SUMMARY:Webinar: New phase 2 clinical data highlights outcomes of EVX-01 in high advanced melanoma
DESCRIPTION:Tune in to see Professor Adnan Khattak present 2-year data from EVAXION’s phase 2 clinical trial in high-risk melanoma, and engage in discussing perspectives for bringing EVX-01 to patients.

LOCATION:Virtual
END:VEVENT
END:VCALENDAR